Molecular & Cellular Characterisation of Oral Lichen Planus
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
The following questions will also be addressed:
- Are the histological architectural tissue changes that take place in oral lichen planus quantifiable using computer based imaging, graph theory and fractal geometry principles? Quantification of these changes would allow the development of a tool to facilitate the accurate measurement of response to treatment.
- What is the nature of such architectural changes and what are the differences with normal, dysplastic and neoplastic epithelia (the investigators have morphometrical data collected from previous research to allow such comparisons).
- Is it possible to produce evidence-based statistical classification into established diagnostic classes using the proposed methodology? This would contribute towards making histopathological diagnosis more quantitative, reproducible and accurate.
- Is it possible to automate such morphometrical analysis/classification? This would allow large data sets to be screened automatically in a shorter time frame and at lower cost than human based screening.
- Is it possible to determine differences in genetics and gene expression of keratinocytes involved in Oral Lichen Planus compared to those of 'normal' tissue by using biopsy material and an in vitro model of oral lichen planus?
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Gabriel Landini, PhD
- Phone Number: +44 0121 466 5519
- Email: G.Landini@bham.ac.uk
Study Contact Backup
- Name: Ana Poveda Gallego, Consultant
- Phone Number: +44 0121 466 6670
- Email: p.g.ana@bham.ac.uk
Study Locations
-
-
West Midlands
-
Birmingham, West Midlands, United Kingdom, B5 7EG
- Birmingham Dental Hospital and School of Dentistry
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Patients registered at Birmingham Dental Hospital and attending a clinic for OLP diagnosis.
Patients will be identified by their normal healthcare consultant and invited to participate.
Informed consent will always be obtained prior to any study related procedures being undertaken.
Description
Inclusion Criteria:
- Patient is 16 years old or over
- Patient is willing and able to provide valid informed consent
- Patient is attending the Oral Lichen Planus clinic and will be having a routine clinical biopsy taken
Exclusion Criteria:
- Patient under 16 years old
- Patient is immunocompromised
- Patients with comorbid disease state e.g. other inflammatory disease
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Histological architecture
Time Frame: Through study completion, (maximum 12 months from the defined end of study)
|
Are the histological architectural tissue changes that take place in oral lichen planus quantifiable using computer based imaging, graph theory and fractal geometry principles?
|
Through study completion, (maximum 12 months from the defined end of study)
|
|
Comparisons with other dysplastic lesions
Time Frame: Through study completion, (maximum 12 months from the defined end of study)
|
What is the nature of such architectural changes and what are the differences with normal, dysplastic and neoplastic epithelia
|
Through study completion, (maximum 12 months from the defined end of study)
|
|
Statistical classifications
Time Frame: Through study completion, (maximum 12 months from the defined end of study)
|
Is it possible to produce evidence-based statistical classification into established diagnostic classes using the proposed methodology
|
Through study completion, (maximum 12 months from the defined end of study)
|
|
Automation of morphological features
Time Frame: Through study completion, (maximum 12 months from the defined end of study)
|
Is it possible to automate such morphometrical analysis/classification?
|
Through study completion, (maximum 12 months from the defined end of study)
|
|
Molecular expression of Oral Lichen Planus markers
Time Frame: Through study completion, (maximum 12 months from the defined end of study)
|
Is it possible to determine differences in genetics and gene expression of keratinocytes involved in Oral Lichen Planus compared to those of 'normal' tissue by using biopsy material and an in vitro model of oral lichen planus?
|
Through study completion, (maximum 12 months from the defined end of study)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Gabriel Landini, Phd, University of Birmingham
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RG_15-112
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.